Tomasz Stoklosa

Tomasz Stoklosa

Warszawski Uniwersytet Medyczny

H-index: 37

Europe-Poland

About Tomasz Stoklosa

Tomasz Stoklosa, With an exceptional h-index of 37 and a recent h-index of 20 (since 2020), a distinguished researcher at Warszawski Uniwersytet Medyczny, specializes in the field of hematology, oncology, genetics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia‐positive lymphoid leukemia to tyrosine kinase inhibitors

Clonal medicine targeting DNA damage response eradicates leukemia

FGFR2 point mutation in 2 cases of pleomorphic adenoma progressing to myoepithelial carcinoma

SARS-CoV-2 Infection in Patients Treated with Azacitidine and Venetoclax for Acute Leukemia: A Report of a Case Series Treated in a Single Institution

Laboratories Can Reliably Detect Clinically Relevant Variants in the TP53 Gene below 10% Allelic Frequency: A Multicenter Study of ERIC, the European Research Initiative on CLL

HRAS mutation positive multiple myeloma in the type 2 CALR mutation positive essential thrombocythemia: A case report

Clonal Targeting of DNA Damage Response Pathways Eradicates Myeloproliferative Neoplasms

Immunologia

Tomasz Stoklosa Information

University

Position

___

Citations(all)

4994

Citations(since 2020)

1320

Cited By

4240

hIndex(all)

37

hIndex(since 2020)

20

i10Index(all)

70

i10Index(since 2020)

33

Email

University Profile Page

Warszawski Uniwersytet Medyczny

Google Scholar

View Google Scholar Profile

Tomasz Stoklosa Skills & Research Interests

hematology

oncology

genetics

Top articles of Tomasz Stoklosa

Title

Journal

Author(s)

Publication Date

Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia‐positive lymphoid leukemia to tyrosine kinase inhibitors

HemaSphere

Lukasz Komorowski

Agnieszka Dabkowska

Joanna Madzio

Agata Pastorczak

Kacper Szczygiel

...

2024/3

Clonal medicine targeting DNA damage response eradicates leukemia

Leukemia

Monika M Toma

Adam Karami

Margaret Nieborowska-Skorska

Kumaraswamy Naidu Chirtala

Monika Pepek

...

2024/1/16

FGFR2 point mutation in 2 cases of pleomorphic adenoma progressing to myoepithelial carcinoma

Contemporary Oncology/Współczesna Onkologia

Julia Pikul

Anna Rzepakowska

Marcin Machnicki

Tomasz Stokłosa

2023/7/1

SARS-CoV-2 Infection in Patients Treated with Azacitidine and Venetoclax for Acute Leukemia: A Report of a Case Series Treated in a Single Institution

Chemotherapy

Joanna Drozd-Sokołowska

Krzysztof Mądry

Joanna Barankiewicz

Katarzyna Kobylińska

Przemysław Biecek

...

2023/3/7

Laboratories Can Reliably Detect Clinically Relevant Variants in the TP53 Gene below 10% Allelic Frequency: A Multicenter Study of ERIC, the European Research Initiative on CLL

Blood

Sarka Pavlova

Jitka Malcikova

Lenka Radova

Silvia Bonfiglio

Jack B Cowland

...

2023/12/1

HRAS mutation positive multiple myeloma in the type 2 CALR mutation positive essential thrombocythemia: A case report

Journal of Cellular and Molecular Medicine

Krzysztof Lewandowski

Agata Kopydłowska

Zuzanna Kanduła

Bartłomiej Sankowski

Marcin Machnicki

...

2023/1

Clonal Targeting of DNA Damage Response Pathways Eradicates Myeloproliferative Neoplasms

Blood

Monika Toma

Margaret Nieborowska-Skorska

Adam Karami

Monika Pepek

Tomasz Stoklosa

...

2023/11/28

Immunologia

Dolores Jaraquemada

2011

Telomere loss is accompanied by decreased pool of shelterin proteins TRF2 and RAP1, elevated levels of TERRA and enhanced glycolysis in imatinib-resistant CML cells

Toxicology in Vitro

Anna Deregowska

Anna Lewinska

Aleksandra Warzybok

Tomasz Stoklosa

Maciej Wnuk

2023/8/1

The interplay between telomeric complex members and BCR:: ABL1 oncogenic tyrosine kinase in the maintenance of telomere length in chronic myeloid leukemia

Journal of Cancer Research and Clinical Oncology

Anna Deręgowska

Monika Pępek

Iwona Solarska

Marcin M Machnicki

Katarzyna Pruszczyk

...

2023/8

The Clinical Tumor Lysis Syndrome in a Patient with Mixed Phenotype Acute Leukemia Undergoing Induction with Venetoclax and Azacitidine: A Case Report

Chemotherapy

Joanna Drozd-Sokolowska

Krzysztof Mądry

Kinga Siewiorek

Magdalena Feliksbrot-Bratosiewicz

Tomasz Stokłosa

...

2022/8/19

Tracking clonal evolution of multiple myeloma using targeted next-generation DNA sequencing

Biomedicines

Aleksander Salomon-Perzyński

Joanna Barankiewicz

Marcin Machnicki

Irena Misiewicz-Krzemińska

Michał Pawlak

...

2022/7/12

Analysis of mutational profile of hypopharyngeal and laryngeal head and neck squamous cell carcinomas identifies KMT2C as a potential tumor suppressor

Frontiers in oncology

Marcin M Machnicki

Anna Rzepakowska

Joanna I Janowska

Monika Pepek

Alicja Krop

...

2022/5/19

Wytyczne postępowania diagnostyczno--terapeutycznego w raku wątrobowokomórkowym

Gastroenterologia Kliniczna. Postępy i Standardy

Halina Cichoż-Lach

Andrzej Cieszanowski

Barbara Górnicka

Michał Grąt

Marek Hartleb

...

2022/1/1

Wytyczne postępowania diagnostyczno-terapeutycznego w raku wątrobowokomórkowym

Onkologia w Praktyce Klinicznej-Edukacja

Maciej Krzakowski

Jarosław Reguła

Halina Cichoż-Lach

Andrzej Cieszanowski

Barbara Górnicka

...

2022

Targeting integrated stress response with ISRIB combined with imatinib treatment attenuates RAS/RAF/MAPK and STAT5 signaling and eradicates chronic myeloid leukemia cells

BMC cancer

Wioleta Dudka

Grazyna Hoser

Shamba S Mondal

Laura Turos-Korgul

Julian Swatler

...

2022/12/2

Whole-exome sequencing in patients with protein aggregate myopathies reveals causative mutations associated with novel atypical phenotypes

Neurological Sciences

Marcin M Machnicki

Valeria Guglielmi

Elia Pancheri

Francesca Gualandi

Lorenzo Verriello

...

2021/7

Results of Polish Adult Leukemia Study Group (PALG) project assessing TP53 mutations with next-generation sequencing technology in relapsed and refractory chronic lymphocytic …

Acta Haematologica Polonica

Monika Pepek

Bartosz Pula

Marcin M Machnicki

Elzbieta Morawiec-Szymonik

Alina Urbanowicz

...

2021

Targeting Integrated Stress Response by ISRIB combined with imatinib attenuates STAT5 signaling and eradicates therapy-resistant Chronic Myeloid Leukemia cells

bioRxiv

Wioleta Dudka

Grażyna Hoser

Shamba S Mondal

Laura Turos-Korgul

Julian Swatler

...

2021/5/7

Co-occurrence of unclassified myeloproliferative neoplasm and giant cell arteritis in a patient treated with allogeneic hematopoietic stem cell transplantation: a case report …

Central European Journal of Immunology

Aleksandra Bogucka-Fedorczuk

Anna Czyż

Andrzej Szuba

Marcin M Machnicki

Monika Pępek

...

2021/1/1

See List of Professors in Tomasz Stoklosa University(Warszawski Uniwersytet Medyczny)